Form 8-K - Current report:
SEC Accession No. 0000950170-22-016472
Filing Date
2022-08-10
Accepted
2022-08-10 16:13:11
Documents
14
Period of Report
2022-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sctl-20220810.htm   iXBRL 8-K 54678
2 EX-99.1 sctl-ex99_1.htm EX-99.1 377724
3 GRAPHIC img53677981_0.jpg GRAPHIC 28509
  Complete submission text file 0000950170-22-016472.txt   610814

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sctl-20220810.xsd EX-101.SCH 2499
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sctl-20220810_pre.xml EX-101.PRE 9908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sctl-20220810_lab.xml EX-101.LAB 13466
8 EXTRACTED XBRL INSTANCE DOCUMENT sctl-20220810_htm.xml XML 4730
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 221151964
SIC: 2834 Pharmaceutical Preparations